Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Molecular Profiling in Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Detection of Early Lung Cancer by Serum Protein Expression Profiling
- Status
- UNKNOWN
- Phase
- N/A
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- N/A
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis
- Status
- UNKNOWN
- Phase
- N/A
Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2